P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

February 2013

Features

Hospitals Prepare for Medicare Cuts

The Need to Reduce the Federal Deficit Puts Seniors and Providers on Notice

In view of changing Medicare payment policies, hospitals reassess pharmacy procedures.
Stephen Barlas

The MAPK (ERK) Pathway

Investigational Combinations for the Treatment of BRAF-Mutated Metastatic Melanoma

The arrival of ipilimumab and vemurafenib has provided oncologists with new choices in a field in which options were slim and the prognosis was grim. Combination therapy may lead to an improved survival benefit.
Jack McCain

Cardiometabolic Consequences of Therapy for Chronic Schizophrenia Using Second-Generation Antipsychotic Agents in a Medicaid Population

Clinical and Economic Evaluation

A health economic model was constructed to predict the 5-year incidence of coronary heart disease and diabetes and associated costs after treatment in patients using second-generation antipsychotic agents.
Alex Ward, PhD, MRPharmS; Peter Quon, MPH; Safiya Abouzaid, PharmD; Noah Haber, MA; Saeed Ahmed, MD; and Edward Kim, MD, MBA

Meeting Highlights

American Society of Hematology

Drug therapies for multiple myeloma, mantle-cell lymphoma, and myelodysplastic syndromes
Walter Alexander

Meeting Highlights

2012 American Society of Health-System Pharmacists Midyear Clinical Meeting & Exhibition

Generic biologics (e.g., biosimilars) and medication safety related to Joint Commission hospital accreditation standards
Michele B. Kaufman, PharmD, RPh

Departments

Medication Errors

Scanning Too Many Orders at Once

The Result: Drug Orders Are Omitted

Drug orders can be accidentally omitted or misread if a scanner pulls too many pages through at once.
Matthew Grissinger, RPh, FASCP

Prescription: Washington

Hospitals Worry About New FDA Proposal for Medical Devices

Technical Complexities of Labels Could Compromise Utility

A proposed FDA rule on unique device identifcation could complicate billing and bar-coding procedures for hospitals.
Stephen Barlas

New Drugs/Drug News/New Medical Devices

FDA approvals, drug indications, and updates

Pharmaceutical Approval Update

Cabozantinib (Cometriq) for metastatic medullary thyroid cancer; ponatinib (Iclusig) for two forms of leukemia; and raxibacumab for inhalational anthrax
Marvin M. Goldenberg, PhD, RPh, MS

Drug Forecast

Bapineuzumab, an Investigational Agent For Alzheimer’s Disease

Farah Khorassani, PharmD, BCPS; and Olga Hilas, PharmD, MPH, BCPS, CGP